CA125 in ovarian tumour tissue at second laparotomy.
Maughan
T S
TS
South Wales Radiotherapy and Oncology Service, Velindre Hospital, Whitchurch, Cardiff, UK.
Fish
R G
RG
Shelley
M D
MD
Jasani
B
B
Williams
G T
GT
Adams
M
M
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D016190:Carboplatin; D002945:Cisplatin / Q000627:therapeutic use; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D007813:Laparotomy; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000276:immunology*
D015295:Antigens, Tumor-Associated, Carbohydrate; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D009944:Organoplatinum Compounds; D016190:Carboplatin; D002945:Cisplatin